Published in Biochim Biophys Acta on September 24, 1981
The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc Natl Acad Sci U S A (1993) 1.57
Thromboxane A synthase-independent production of 12-hydroxyheptadecatrienoic acid, a BLT2 ligand. J Lipid Res (2013) 0.84
Production of platelet thromboxane A2 inactivates purified human platelet thromboxane synthase. Biochem J (1986) 0.79
On the cellular metabolism of the click chemistry probe 19-alkyne arachidonic acid. J Lipid Res (2016) 0.75
Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest (1974) 3.65
Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. J Pharmacol Exp Ther (1998) 1.66
Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura. Lancet (1981) 1.49
Oxidoreductases in lipoxin A4 metabolic inactivation: a novel role for 15-onoprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase in inflammation. J Biol Chem (2000) 1.35
Metabolism of prostaglandin glycerol esters and prostaglandin ethanolamides in vitro and in vivo. J Biol Chem (2001) 1.30
Stimulation of de novo synthesis of prostaglandin G/H synthase in human endothelial cells by phorbol ester. J Biol Chem (1988) 1.28
Site-directed mutagenesis of the conserved tyrosine 151 of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase yields a catalytically inactive enzyme. Biochem Biophys Res Commun (1991) 1.24
Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group. J Infect Dis (1999) 1.20
Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. Am Rev Respir Dis (1984) 1.19
Isozymes of pyruvate kinase in vertebrates: their physical, chemical, kinetic and immunological properties. Int J Biochem (1978) 1.18
Risk factors for the spread of HIV and other sexually transmitted infections among men who have sex with men infected with HIV in Lima, Peru. Sex Transm Infect (2008) 1.16
On the inhibitory potency of imidazole and its derivatives on thromboxane synthetase. Biochem Biophys Res Commun (1978) 1.14
Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infect Immun (2006) 1.11
Mechanisms of steroid oxidation by microorganisms. XIV. Pathway of cholesterol side-chain degradation. Biochemistry (1968) 1.11
Plasma secretin concentrations in fasting and postprandial state in man. Am J Dig Dis (1978) 1.09
Permeability of human endothelial monolayers: effect of vasoactive agonists and cAMP. J Appl Physiol (1985) (1989) 1.06
Listeria monocytogenes L forms. I. Induction maintenance, and biological characteristics. J Bacteriol (1968) 1.05
Genotypic and phenotypic characterization of enterotoxigenic Escherichia coli strains isolated from Peruvian children. J Clin Microbiol (2010) 1.05
Agonist-induced lipoxin A4 generation: detection by a novel lipoxin A4-ELISA. Lipids (1993) 1.04
Expression and functional characterization of mutant human CXCR4 in insect cells: role of cysteinyl and negatively charged residues in ligand binding. Arch Biochem Biophys (2000) 1.03
15-Hydroxyprostaglandin dehydrogenase. J Lipid Mediat Cell Signal (1995) 1.02
Release of arachidonate from diglyceride in human platelets requires the sequential action of a diglyceride lipase and a monoglyceride lipase. Biochem Biophys Res Commun (1981) 1.01
C-22 acid intermediates in the microbiological cleavage of the cholesterol side chain. J Am Chem Soc (1967) 1.01
The Common Rat as a Source of Erysipelothrix rhusiopathiae. Am J Public Health Nations Health (1947) 1.01
Synergistic stimulation of thromboxane biosynthesis by calcium ionophore and phorbol ester or thrombin in human platelets. Biochem Biophys Res Commun (1985) 1.00
Mechanisms of steroid oxidation by microorganisms. 13. C22 acid intermediates in the degradation of the cholesterol side chain. Biochemistry (1968) 1.00
The mechanism of microbial conversion of cholesterol into 17-keto steroids. J Am Chem Soc (1967) 0.99
Site-directed mutagenesis of cysteinyl and serine residues of human thromboxane A2 receptor in insect cells. Arch Biochem Biophys (1996) 0.99
Enzymatic synthesis of (15s)-[15-3h]prostaglandins and their use in the development of a simple and sensitive assay for 15-hydroxyprostaglandin dehydrogenase. Biochemistry (1976) 0.98
Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. J Biol Chem (1990) 0.98
Resolution into two different forms and study of the properties of phosphatidylinositol-specific phospholipase C from human platelet cytosol. Biochim Biophys Acta (1982) 0.96
Purification and characterization of phosphatidylinositol kinase from porcine liver microsomes. Biochim Biophys Acta (1988) 0.95
Characterization of recombinant human CXCR4 in insect cells: role of extracellular domains and N-glycosylation in ligand binding. Arch Biochem Biophys (1999) 0.95
Activated microglia are the principal glial source of thromboxane in the central nervous system. Neurochem Int (1996) 0.95
Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. I. A pertussis toxin-sensitive pathway is involved. J Cell Biol (1989) 0.94
Induction of NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase expression by androgens in human prostate cancer cells. Biochem Biophys Res Commun (2000) 0.94
Gossypol, a potent inhibitor of arachidonate 5- and 12-lipoxygenases. Biochim Biophys Acta (1985) 0.93
Thromboxanes: synthase and receptors. J Biomed Sci (1998) 0.93
Inhibition of thromboxane synthesis and platelet aggregation by pyridine and its derivatives. Adv Prostaglandin Thromboxane Res (1980) 0.93
Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor. J Clin Endocrinol Metab (1994) 0.92
Relationship between types of surface shear stress profiles and membrane fouling. Water Res (2011) 0.91
9-Hydroxyprostaglandin dehydrogenase from rat kidney. Purification to homogeneity and partial characterization. J Biol Chem (1980) 0.91
Squalene epoxidase of rat liver. J Biol Chem (1972) 0.91
Biosynthesis of prostaglandins in rabbit kidney medulla. Properties of prostaglandin synthase. Biochem J (1976) 0.90
The effect of shear stress on the uptake and metabolism of arachidonic acid by human endothelial cells. Biochim Biophys Acta (1989) 0.90
Phorbol ester, 1,2-diacylglycerol, and collagen induce inhibition of arachidonic acid incorporation into phospholipids in human platelets. J Biol Chem (1989) 0.90
Evidence for a proteolytic modification of liver pyruvate kinase in fasted rats. Arch Biochem Biophys (1979) 0.90
Prostacyclin stabilising factor deficiency in thrombotic thrombocytopenic purpura. Lancet (1982) 0.90
Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim Biophys Acta (1994) 0.89
A radioimmunoassay for 6-ketoprostaglandin E1. Prostaglandins Leukot Med (1982) 0.89
Monoglyceride and diglyceride lipases from human platelet microsomes. Biochim Biophys Acta (1988) 0.88
Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J Neurochem (1990) 0.88
Radioimmunoassay of motilin. Validation and studies on the relationship between plasma motilin and interdigestive myoelectric activity of the duodenum of dog. Am J Dig Dis (1978) 0.88
Rapid extraction of secretin from plasma by XAD-2 resin and its application in the radioimmunoassay of secretin. Anal Biochem (1978) 0.87
Stimulation of endothelial cell prostacyclin formation by interleukin-2. Lymphokine Res (1986) 0.87
Phosphorylation and desensitization of the human thromboxane receptor-alpha by G protein-coupled receptor kinases. J Pharmacol Exp Ther (2001) 0.87
Platelet modulation of polymorphonuclear leukocyte shear induced aggregation. Blood (1986) 0.87
Angiotensin i-converting enzyme in the nephron. Life Sci (1976) 0.86
Rapid method for the isolation of Listeria monocytogenes from experimentally infected mice. Appl Microbiol (1971) 0.86
Phenylalanine 138 in the second intracellular loop of human thromboxane receptor is critical for receptor-G-protein coupling. Biochem Biophys Res Commun (1999) 0.86
Development of radioimmunoassay for thromboxane B2. Anal Biochem (1978) 0.86
Interaction between lymphocytes and platelets in the synthesis of prostacyclin. J Clin Invest (1987) 0.86
Plasma secretin and gastrin responses to a meat meal and duodenal acidification in dogs. Am J Physiol (1976) 0.85
Prostaglandin 9-ketoreductase/type II 15-hydroxyprostaglandin dehydrogenase is not a prostaglandin specific enzyme. Biochem Biophys Res Commun (1981) 0.85
Radioimmunoassay of vasoactive intestinal polypeptide. Anal Biochem (1979) 0.85
Immunoaffinity purification and characterization of thromboxane synthase from porcine lung. J Biol Chem (1986) 0.85
Abnormal platelet response to thromboxane A2. J Clin Invest (1981) 0.84
Stimulations of arachidonate release and inositol-1,4,5-triphosphate formation are mediated by distinct G-proteins in human platelets. Biochem Biophys Res Commun (1987) 0.84
3,4-dihydroxy-9,10-secoandrosta-1,3-5(10)-triene-9,17-dione 4,-5-dioxygenase from Nocardia restrictus. II. Kinetic studies. J Biol Chem (1970) 0.83
Monoclonal antibodies to thromboxane synthase from porcine lung. Production and application to development of a tandem immunoradiometric assay. J Biol Chem (1986) 0.83
Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells. Biochem J (1995) 0.83
Simultaneous radioimmunoassay of Secretin and gastrin. Anal Biochem (1976) 0.83
Impairment of secretin release in celiac sprue. Am J Dig Dis (1978) 0.82
Kinetic evidence of a distinct regulatory site on 15-hydroxyprostaglandin dehydrogenase. Adv Prostaglandin Thromboxane Res (1976) 0.82
Roles of the vagus in endogenous release of secretin and exocrine pancreatic secretion in dog. Adv Exp Med Biol (1978) 0.82
Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester. Biochem J (1991) 0.82
Survival of Listeria monocytogenes in experimentally infected mice. Appl Microbiol (1971) 0.82
Threonine 188 is critical for interaction with NAD+ in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. Biochem Biophys Res Commun (1999) 0.82
The role of N-glycosylation of human thromboxane A2 receptor in ligand binding. Arch Biochem Biophys (1998) 0.82
Characterization of the genomic structure and promoter of the mouse NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene. Biochem Biophys Res Commun (1997) 0.82
Serum prostacyclin binding defects in thrombotic thrombocytopenic purpura. J Clin Invest (1985) 0.82
Hypoxia stimulates prostacyclin generation by dog lung in vitro. Prostaglandins Leukot Med (1982) 0.82
A simple and sensitive assay for 9-hydroxyprostaglandin dehydrogenase. Anal Biochem (1977) 0.81
Burn injury with infection alters prostaglandin E2 synthesis and metabolism. J Trauma (1999) 0.81
Purification, cDNA cloning and expression of 15-oxoprostaglandin 13-reductase from pig lung. Biochem J (1998) 0.81
Intramolecular ADP-ribose transfer reactions and calcium signalling. Potential role of 2'-phospho-cyclic ADP-ribose in oxidative stress. Adv Exp Med Biol (1997) 0.81
Prostaglandin 9-ketoreductase and type II 15-hydroxyprostaglandin dehydrogenase from swine kidney are alternate activities of a single enzyme protein. Biochem Biophys Res Commun (1981) 0.81
3,4-dihydroxy-9,10-secoandrosta-1,3,5(10)-triene-9,17-dione 4,5-dioxygenase from Nocardia restrictus. I. Isolation of the enzyme and study of its physical and chemical properties. J Biol Chem (1970) 0.80
Selective inhibition of thromboxane synthetase by pyridine and its derivatives. Arch Biochem Biophys (1980) 0.80
Prostaglandin E2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase. J Trauma (1998) 0.80
The Escherichia coli-derived Fab fragment of the IgM/kappa antibody IN-1 recognizes and neutralizes myelin-associated inhibitors of neurite growth. Eur J Biochem (1996) 0.80
Observations of plasma secretin levels by radioimmunoassay in response to duodenal acidification and to a meat meal in humans. Am J Dig Dis (1976) 0.80
Preparation of 125I-labeled secretin of high specific radioactivity. Anal Biochem (1975) 0.80
Stimulation of cyclic nucleotide phosphodiesterase by products of phosphatidylinositol metabolism catalyzed by phospholipase A2. Arch Biochem Biophys (1982) 0.80
Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia. J Neurosurg (1986) 0.80
Radioimmunological assay of prostacyclin synthetase activity. Prostaglandins Med (1980) 0.80
Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Arch Toxicol (1995) 0.79
Stimulation of prostaglandin E2 synthesis by interleukin-1beta is amplified by interferons but inhibited by interleukin-4 in human amnion-derived WISH cells. Biochim Biophys Acta (1996) 0.79
Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Res (1988) 0.79